Summary
- Current Price
- As of today, VKTX price is $31.60, up +0.29% in the most recent trading session on
- Current Price All-Time High
- VKTX price is currently -68.21% below its historical high of $99.41 set on
- Market Cap
- VKTX current market cap is $4B, up +10.96% over the past 365 days
- PE Ratio
- VKTX PE ratio is unknown
- Revenue
- VKTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for VKTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Viking Therapeutics, Inc. |
| Ticker | NASDAQ: VKTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | vikingtherapeutics.com |
| Employees | 48 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $31.60 | |
| Price, 1D Change | +0.29% | |
| $4B | ||
| - | ||
| - | ||
| 1.47 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$3.19 | ||
| EPS, 1Y Change | -216.51% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$3.19 | ||
| EPS Estimate | N/A | -$4.11 |
| EPS Est. Change | N/A | -28.91% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $31.60 | |
| Price Target | - | $99.50 |
| Price Tgt. Change | - | +214.87% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.96 | -$1.01 | -4.93% | |
| -$2.61 | -$3.19 | -22.14% | |
| -$4.11 | N/A | -28.91% | |
| -$4.57 | N/A | -43.22% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $31.60 | |
| $31.60 | ||
| SMA 200 vs Price | -0.01% | |
| $32.15 | ||
| SMA 50 vs Price | +1.73% | |
| 1.47 | ||
| $1.88 | ||
| 48.81 | ||
| 67.14% | ||
| 79.11% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$3.19 | ||
| -$431.00K | ||
| - | ||
| -$393.34M | ||
| - | ||
| -$359.64M | ||
| - | ||
| -$392.91M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 9.33 | ||
| 9.33 | ||
| - | ||
| - | ||
| 25.55 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 5.59 | ||
| -7.30 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $639.06M | ||
| $705.74M | ||
| $715.73M | ||
| $715.60M | ||
| $76.67M | ||
| $76.67M | ||
| $137.00K | ||
| $137.00K | ||
| $53.25M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $359.64M | ||
| $392.91M | ||
| $431.00K | ||
| $0.00 | ||
| $431.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$278.69M | ||
| $341.39M | ||
| $76.44M | ||
| $0.00 | ||
| -$278.69M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Canaccord Genuity | ||
| JP Morgan | → | |
| Morgan Stanley | → | |
| HC Wainwright & Co. | → | |
| BTIG | → | |
| HC Wainwright & Co. | → | |
| Raymond James | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with VKTX
FAQ
What is the ticker symbol for Viking Therapeutics, Inc.?
The ticker symbol for Viking Therapeutics, Inc. is NASDAQ:VKTX
Does Viking Therapeutics, Inc. pay dividends?
No, Viking Therapeutics, Inc. does not pay dividends
What sector is Viking Therapeutics, Inc. in?
Viking Therapeutics, Inc. is in the Healthcare sector
What industry is Viking Therapeutics, Inc. in?
Viking Therapeutics, Inc. is in the Biotechnology industry
What country is Viking Therapeutics, Inc. based in?
Viking Therapeutics, Inc. is headquartered in United States
When did Viking Therapeutics, Inc. go public?
Viking Therapeutics, Inc. initial public offering (IPO) was on April 28, 2015
Is Viking Therapeutics, Inc. in the S&P 500?
No, Viking Therapeutics, Inc. is not included in the S&P 500 index
Is Viking Therapeutics, Inc. in the NASDAQ 100?
No, Viking Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Viking Therapeutics, Inc. in the Dow Jones?
No, Viking Therapeutics, Inc. is not included in the Dow Jones index
When was Viking Therapeutics, Inc. last earnings report?
Viking Therapeutics, Inc.'s most recent earnings report was on February 11, 2026
When does Viking Therapeutics, Inc. report earnings?
The next expected earnings date for Viking Therapeutics, Inc. is April 29, 2026
Data Sources & References
- VKTX Official Website www.vikingtherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1607678/000119312526046876/0001193125-26-046876-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1607678/000119312526046876/0001193125-26-046876-index.htm
- VKTX Profile on Yahoo Finance finance.yahoo.com/quote/VKTX
- VKTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vktx